After raising $ 500 million in funding, Ro spends some of that money to build its women’s health brand.
The direct consumer health startup acquired Modern Fertility, a startup that offers home fertility testing, for $ 225 million. As part of the deal, Afton Vechery and Carly Leahy, co-founders of Modern Fertility, will lead Ro’s women’s health business.
“We now have the opportunity to drastically accelerate our vision of supporting women in every step of the journey in reproductive care and beyond,” Vechery, CEO of Modern Fertility, said in a press release.
Founded in 2017, Ro started with two direct consumer health brands: Roman, for men, and Rory, for women. It also has a smoking cessation brand, Zero.
It is one of several companies that sell prescription mail orders for regular conditions after a brief online consultation, which usually involves filling out an evaluation and waiting for a doctor to review it.
Since then, Ro has rapidly expanded its business to offer a wider range of services. He added virtual urgent assistance visits and home testing with his recent acquisition of Workpath.
Modern fertility would be based on this by offering hormonal tests at home and individual consultations with a fertility nurse. It uses a cash payment model similar to Ro’s. Its main product is a finger-fisted hormonal test that sells for about $ 160, although the company warns that its test can only be used for wellness purposes, not to make a diagnosis.
The startup also sells pregnancy tests, ovulation tests and supplements.
The agreement would not only increase Ro’s women’s health business, but would also allow modern fertility to expand its reach through Ro’s infrastructure.